160 related articles for article (PubMed ID: 20406106)
1. Impaired metabolic effects of a thyroid hormone receptor beta-selective agonist in a mouse model of diet-induced obesity.
Castillo M; Freitas BC; Rosene ML; Drigo RA; Grozovsky R; Maciel RM; Patti ME; Ribeiro MO; Bianco AC
Thyroid; 2010 May; 20(5):545-53. PubMed ID: 20406106
[TBL] [Abstract][Full Text] [Related]
2. A TRbeta-selective agonist confers resistance to diet-induced obesity.
Amorim BS; Ueta CB; Freitas BC; Nassif RJ; Gouveia CH; Christoffolete MA; Moriscot AS; Lancelloti CL; Llimona F; Barbeiro HV; de Souza HP; Catanozi S; Passarelli M; Aoki MS; Bianco AC; Ribeiro MO
J Endocrinol; 2009 Nov; 203(2):291-9. PubMed ID: 19713219
[TBL] [Abstract][Full Text] [Related]
3. Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome.
Filgueira CS; Nicolov E; Hood RL; Ballerini A; Garcia-Huidobro J; Lin JZ; Fraga D; Webb P; Sabek OM; Gaber AO; Phillips KJ; Grattoni A
Int J Obes (Lond); 2016 Nov; 40(11):1776-1783. PubMed ID: 27460601
[TBL] [Abstract][Full Text] [Related]
4. PPAR-α agonist elicits metabolically active brown adipocytes and weight loss in diet-induced obese mice.
Rachid TL; Penna-de-Carvalho A; Bringhenti I; Aguila MB; Mandarim-de-Lacerda CA; Souza-Mello V
Cell Biochem Funct; 2015 Jun; 33(4):249-56. PubMed ID: 25959716
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats.
Villicev CM; Freitas FR; Aoki MS; Taffarel C; Scanlan TS; Moriscot AS; Ribeiro MO; Bianco AC; Gouveia CH
J Endocrinol; 2007 Apr; 193(1):21-9. PubMed ID: 17400799
[TBL] [Abstract][Full Text] [Related]
6. Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice.
Kroon J; Koorneef LL; van den Heuvel JK; Verzijl CRC; van de Velde NM; Mol IM; Sips HCM; Hunt H; Rensen PCN; Meijer OC
Endocrinology; 2018 Jan; 159(1):535-546. PubMed ID: 28938459
[TBL] [Abstract][Full Text] [Related]
7. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.
Johansson L; Rudling M; Scanlan TS; Lundåsen T; Webb P; Baxter J; Angelin B; Parini P
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10297-302. PubMed ID: 16006512
[TBL] [Abstract][Full Text] [Related]
8. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.
Bryzgalova G; Effendic S; Khan A; Rehnmark S; Barbounis P; Boulet J; Dong G; Singh R; Shapses S; Malm J; Webb P; Baxter JD; Grover GJ
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):262-7. PubMed ID: 18621127
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone receptor-beta-selective agonist GC-24 spares skeletal muscle type I to II fiber shift.
Miyabara EH; Aoki MS; Soares AG; Saltao RM; Vilicev CM; Passarelli M; Scanlan TS; Gouveia CH; Moriscot AS
Cell Tissue Res; 2005 Aug; 321(2):233-41. PubMed ID: 15947969
[TBL] [Abstract][Full Text] [Related]
10. The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice.
Fukuda-Tsuru S; Kakimoto T; Utsumi H; Kiuchi S; Ishii S
Eur J Pharmacol; 2014 Jan; 723():207-15. PubMed ID: 24309217
[TBL] [Abstract][Full Text] [Related]
11. Miglitol prevents diet-induced obesity by stimulating brown adipose tissue and energy expenditure independent of preventing the digestion of carbohydrates.
Sasaki T; Shimpuku M; Kitazumi T; Hiraga H; Nakagawa Y; Shibata H; Okamatsu-Ogura Y; Kikuchi O; Kim HJ; Fujita Y; Maruyama J; Susanti VY; Yokota-Hashimoto H; Kobayashi M; Saito M; Kitamura T
Endocr J; 2013; 60(10):1117-29. PubMed ID: 23995917
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone acting via TRβ induces expression of browning genes in mouse bone marrow adipose tissue.
Lindsey RC; Mohan S
Endocrine; 2017 Apr; 56(1):109-120. PubMed ID: 28229360
[TBL] [Abstract][Full Text] [Related]
13. Puerariae lobatae root extracts and the regulation of brown fat activity.
Buhlmann E; Horváth C; Houriet J; Kiehlmann E; Radtke J; Marcourt L; Wolfender JL; Wolfrum C; Schröder S
Phytomedicine; 2019 Nov; 64():153075. PubMed ID: 31476558
[TBL] [Abstract][Full Text] [Related]
14. MetAP2 inhibition increases energy expenditure through direct action on brown adipocytes.
Huang HJ; Holub C; Rolzin P; Bilakovics J; Fanjul A; Satomi Y; Plonowski A; Larson CJ; Farrell PJ
J Biol Chem; 2019 Jun; 294(24):9567-9575. PubMed ID: 31048375
[TBL] [Abstract][Full Text] [Related]
15. Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome.
Poekes L; Lanthier N; Leclercq IA
Clin Sci (Lond); 2015 Dec; 129(11):933-49. PubMed ID: 26359253
[TBL] [Abstract][Full Text] [Related]
16. The effects of oxytocin to rectify metabolic dysfunction in obese mice are associated with increased thermogenesis.
Yuan J; Zhang R; Wu R; Gu Y; Lu Y
Mol Cell Endocrinol; 2020 Aug; 514():110903. PubMed ID: 32531419
[TBL] [Abstract][Full Text] [Related]
17. In vivo activity of the thyroid hormone receptor beta- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain.
Grijota-Martínez C; Samarut E; Scanlan TS; Morte B; Bernal J
Endocrinology; 2011 Mar; 152(3):1136-42. PubMed ID: 21239431
[TBL] [Abstract][Full Text] [Related]
18. The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity.
Trost SU; Swanson E; Gloss B; Wang-Iverson DB; Zhang H; Volodarsky T; Grover GJ; Baxter JD; Chiellini G; Scanlan TS; Dillmann WH
Endocrinology; 2000 Sep; 141(9):3057-64. PubMed ID: 10965874
[TBL] [Abstract][Full Text] [Related]
19. Thyroid Hormone Receptor β Agonist Induces β-Catenin-Dependent Hepatocyte Proliferation in Mice: Implications in Hepatic Regeneration.
Alvarado TF; Puliga E; Preziosi M; Poddar M; Singh S; Columbano A; Nejak-Bowen K; Monga SP
Gene Expr; 2016; 17(1):19-34. PubMed ID: 27226410
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes.
Grover GJ; Mellström K; Malm J
Curr Vasc Pharmacol; 2007 Apr; 5(2):141-54. PubMed ID: 17430219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
